Midatech appoints Jim Phillips CEO
This article was originally published in Clinica
Executive Summary
Abingdon, UK-based Midatech, a manufacturer of biocompatible gold nanoparticles (GNPs) with applications across several industries (including therapeutics, diagnostics and medical imaging) has named Dr Jim Phillips chief executive officer. Dr Phillips joins the company from UK consumer healthcare firm Healthcare Brands International, where he has been CEO since 2010. Founded in 2000, privately-held Midatech has a pipeline of product candidates in clinical and preclinical development for the treatment of diabetes and a variety of cancers.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.